{ "company_number": "08312703", "name": "Silicon Pharma Limited", "url": "/company/08312703", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2012-11-29", "dissolved_on": null, "sic_codes": [ { "code": "46460", "description": "Wholesale of pharmaceutical goods", "section": "G", "section_name": "Wholesale and retail trade; repair of motor vehicles and motorcycles", "url": "/sic/46460" } ], "registered_address": { "id": 2708616, "url": "/address/2708616", "line1": "20 OLIVER BUSINESS PARK", "line2": "OLIVER ROAD", "post_town": "LONDON", "county": "", "country": "ENGLAND", "postcode": "NW10 7JB" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/08312703", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2026-09-30", "last_made_up": "2024-12-31", "category": "TOTAL EXEMPTION FULL", "filings": [ { "url": "/company/08312703/accounts/2024-12-31", "made_up_date": "2024-12-31", "period_start": "2024-12-31", "period_end": "2024-12-31", "entity_name": "Silicon Pharma Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "233401.00", "debtors": "225146.00", "cash_bank_in_hand": "47173.00", "current_assets": "397338.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "125464.00", "total_assets_less_current_liabilities": "358865.00", "net_assets_liabilities": "53325.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2025.zip" }, { "url": "/company/08312703/accounts/2023-12-31", "made_up_date": "2023-12-31", "period_start": "2023-12-31", "period_end": "2023-12-31", "entity_name": "Silicon Pharma Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "128153.00", "debtors": "283447.00", "cash_bank_in_hand": "91186.00", "current_assets": "498156.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "211008.00", "total_assets_less_current_liabilities": "339161.00", "net_assets_liabilities": "11480.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2024.zip" }, { "url": "/company/08312703/accounts/2022-12-31", "made_up_date": "2022-12-31", "period_start": "2022-12-31", "period_end": "2022-12-31", "entity_name": "Silicon Pharma Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "103730.00", "debtors": "84120.00", "cash_bank_in_hand": "1836.00", "current_assets": "204351.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-49645.00", "total_assets_less_current_liabilities": "54085.00", "net_assets_liabilities": "13658.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2023.zip" }, { "url": "/company/08312703/accounts/2021-12-31", "made_up_date": "2021-12-31", "period_start": "2021-12-31", "period_end": "2021-12-31", "entity_name": "Silicon Pharma Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "115771.00", "debtors": "102773.00", "cash_bank_in_hand": "21288.00", "current_assets": "318244.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-46148.00", "total_assets_less_current_liabilities": "69623.00", "net_assets_liabilities": "25339.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2022.zip" }, { "url": "/company/08312703/accounts/2020-12-31", "made_up_date": "2020-12-31", "period_start": "2020-12-31", "period_end": "2020-12-31", "entity_name": "Silicon Pharma Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "76684.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "139308.00", "creditors_due_within_one_year": "148159.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-8851.00", "total_assets_less_current_liabilities": "67833.00", "net_assets_liabilities": "21731.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "21731.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2021.zip" }, { "url": "/company/08312703/accounts/2019-12-31", "made_up_date": "2019-12-31", "period_start": "2019-12-31", "period_end": "2019-12-31", "entity_name": "Silicon Pharma Limited", "dormant": false, "average_employees": "0.00", "tangible_fixed_assets": "78134.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "103780.00", "creditors_due_within_one_year": "159126.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-55346.00", "total_assets_less_current_liabilities": "22788.00", "net_assets_liabilities": "21411.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "21411.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2020.zip" }, { "url": "/company/08312703/accounts/2018-12-31", "made_up_date": "2018-12-31", "period_start": "2018-12-31", "period_end": "2018-12-31", "entity_name": "Silicon Pharma Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "79946.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "35984.00", "creditors_due_within_one_year": "93410.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-57426.00", "total_assets_less_current_liabilities": "22520.00", "net_assets_liabilities": "20708.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "20708.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2019.zip" }, { "url": "/company/08312703/accounts/2017-12-31", "made_up_date": "2017-12-31", "period_start": "2017-12-31", "period_end": "2017-12-31", "entity_name": "Silicon Pharma Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "10286.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "29907.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "22468.00", "total_assets_less_current_liabilities": "32754.00", "net_assets_liabilities": "30800.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "30800.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2018.zip" }, { "url": "/company/08312703/accounts/2016-12-31", "made_up_date": "2016-12-31", "period_start": "2016-12-31", "period_end": "2016-12-31", "entity_name": "Silicon Pharma Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "12192.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "33515.00", "creditors_due_within_one_year": "25270.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "8245.00", "total_assets_less_current_liabilities": "20437.00", "net_assets_liabilities": "17999.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "17899.00", "shareholder_funds": "17999.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2017.zip" }, { "url": "/company/08312703/accounts/2015-12-31", "made_up_date": "2015-12-31", "period_start": "2015-12-31", "period_end": "2015-12-31", "entity_name": "Silicon Pharma Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "12150.00", "cash_bank_in_hand": "6021.00", "current_assets": "18171.00", "creditors_due_within_one_year": "29970.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-11799.00", "total_assets_less_current_liabilities": "-11799.00", "net_assets_liabilities": "-11799.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "-11899.00", "shareholder_funds": "-11799.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2016.zip" }, { "url": "/company/08312703/accounts/2014-12-31", "made_up_date": "2014-12-31", "period_start": "2014-12-31", "period_end": "2014-12-31", "entity_name": "Silicon Pharma Limited", "dormant": true, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": null, "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": null, "total_assets_less_current_liabilities": null, "net_assets_liabilities": "100.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2015.zip" }, { "url": "/company/08312703/accounts/2013-11-30", "made_up_date": "2013-11-30", "period_start": "2013-11-30", "period_end": "2013-11-30", "entity_name": "Silicon Pharma Limited", "dormant": true, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": null, "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": null, "total_assets_less_current_liabilities": null, "net_assets_liabilities": "100.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2014.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/08312703/filing-history" }, "confirmation_statement": { "next_due": "2027-06-25", "last_made_up": "2026-06-11" }, "officers": [ { "name": "PATEL, Chiragkumar Ranchhodbhai", "person_url": "/person/5856805", "role": "director", "appointed_on": "2012-11-29", "resigned_on": null, "nationality": "British", "occupation": "", "source": "stream", "retrieved_at": "2026-07-13T18:59:03+00:00" }, { "name": "PATEL, Chiragkumar", "person_url": "/person/5856818", "role": "secretary", "appointed_on": "2012-11-29", "resigned_on": null, "nationality": "", "occupation": "", "source": "stream", "retrieved_at": "2026-07-13T18:59:03+00:00" } ], "psc": [ { "name": "Mrs Shilpa Patel", "kind": "individual-person-with-significant-control", "person_url": "/person/4633883", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent" ], "notified_on": "2017-01-01", "ceased_on": "2025-05-30", "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Mr Chirag Patel", "kind": "individual-person-with-significant-control", "person_url": "/person/861428", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-75-to-100-percent", "voting-rights-75-to-100-percent", "right-to-appoint-and-remove-directors" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "British", "country_of_residence": "England", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-02T05:12:20.351914+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }